Related Experiment Video
Updated: Jan 11, 2026
07:13
Author Spotlight: Developing Parmodulins to Target Protease-Activated Receptors for Inflammation Control
Published on: May 24, 2024
912
The Molecular Mechanism of PDE1 Regulation.
Jacob Nielsen1, Morten Langgård2, Josefine Fussing Tengberg1
1Molecular and Single Cell Pharmacology, H. Lundbeck A/S, Valby, 2500 Copenhagen, Denmark.
Cells
|November 13, 2025
Summary
Phosphodiesterase 1 (PDE1) is regulated by calcium and calmodulin. Calcium binding causes a conformational change, releasing the inhibitory domain and activating PDE1, offering new therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Pharmacology
Background:
- Phosphodiesterase 1 (PDE1) enzymes regulate cyclic nucleotide signaling.
- PDE1A, PDE1B, and PDE1C are calcium-regulated and found in the brain, heart, and vasculature.
- The precise regulatory mechanism of PDE1, despite identified domains, remains unclear.
Purpose of the Study:
- To elucidate the molecular mechanism governing PDE1 regulation.
- To investigate the interplay between calcium, calmodulin, and PDE1 structure.
- To establish a framework for understanding PDE1's role in cellular signaling.
Main Methods:
- Experimental investigation of PDE1 regulatory mechanisms.
- Utilizing AlphaFold structure predictions to model molecular interactions.
- Comparative analysis with other phosphodiesterase families like PDE4.
Main Results:
- PDE1 regulation involves an inhibitory domain blocking the catalytic site in a calcium-free state.
- Calcium/calmodulin binding induces a conformational change, displacing the inhibitory domain and activating PDE1.
- This mechanism is distinct from GAF-domain-mediated regulation seen in other PDEs.
Conclusions:
- A novel model for PDE1 regulation is proposed, involving calcium-dependent release of an autoinhibitory domain.
- This finding clarifies PDE1's role in calcium and cyclic nucleotide signaling.
- Understanding PDE1 regulation offers potential for developing targeted pharmacological interventions.
Related Concept Videos
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
542
Phosphodiesterase 5 (PDE5) inhibitors are potent enzymes that function to hydrolyze cyclic nucleotides to their corresponding 5' monophosphates. Their unique biochemical properties have been applied in treating Pulmonary Arterial Hypertension (PAH).
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
542
01:28Nitric Oxide Signaling Pathway
6.1K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.1K
01:09GPCRs Regulate Adenylyl Cylase Activity
7.3K
Some GPCRs transmit signals through adenylyl cyclase (AC), a transmembrane enzyme. AC helps synthesize second messenger cyclic adenosine monophosphate (cAMP). AC catalyzes cyclization reaction and converts ATP to cAMP by releasing a pyrophosphate. The pyrophosphate is further hydrolyzed to phosphate by the enzyme pyrophosphatase, which drives cAMP synthesis to completion. However, cAMP is rapidly degraded to 5′ AMP by the enzymes phosphodiesterase (PDE), preventing overstimulation of...
7.3K
01:21G-Protein Gated Ion Channels
5.5K
GPCRs are primarily responsible for our sense of smell, taste, and vision. The binding of a sensory stimulus activates GPCR to stimulate effector proteins, many of which are ion channels in the sensory organs. GPCRs modulate the opening and closing of the target ion channels either directly by binding them, or by releasing second messengers that activate these channels. As ions move across the membrane, the membrane potential is altered, which induces an appropriate response.
Sensory...
Sensory...
5.5K
01:22Amplifying Signals via Enzymatic Cascade
17.0K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
17.0K
01:12GPCR Desensitization
7.9K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
7.9K